Skip to main content
Log in

Antibiotic Policies

Economics and Effectiveness from a UK Perspective

  • Section 5: Antibiotic Usage: Policy, Clinical and Pharmacoeconomic Outcomes
  • Short Communication
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Davey P, Malek M, Dodd T. Pharmacoeconomics: the truth. Lancet 1993; 341: 1097–8.

    Article  PubMed  CAS  Google Scholar 

  2. Samuelson PA. Economics. New York: McGraw Hill, 1976.

    Google Scholar 

  3. Davey P, Rutherford D, Graham B, et al. Repeat consultations after antibiotic prescribing for respiratory infection in one general practice. Br J Gen Pract 1994; 44: 509–13.

    PubMed  CAS  Google Scholar 

  4. Nathwani D, MacDonald T, Davey P. Cost-effectiveness of acyclovir for varicella infections in immunocompetent patients: a British perspective. Infect Dis Clin Pract 1995; 4: 138–45.

    Article  Google Scholar 

  5. Mason J, Drummond M. Reporting guidelines for economic studies. Health Econ 1995; 4: 85–94.

    Article  PubMed  CAS  Google Scholar 

  6. Davey PG, Parker SE, Malek MM. Pharmacoeconomics of antibacterial treatment. PharmacoEconomics 1992; 1: 409–37.

    Article  PubMed  CAS  Google Scholar 

  7. Ford LC, Hammil HA, Lebherz TB. Cost-effective use of antibiotic prophylaxis for cesarean section. Am J Obstet Gynecol 1987; 157: 506–10.

    PubMed  CAS  Google Scholar 

  8. Keane D, James D. Prophylactic antibiotics at caesarean section do not reduce costs. Health Trends 1993; 25: 84–7.

    PubMed  CAS  Google Scholar 

  9. Mead PB. Infection-control issues. In: Pastorek JG, editor. Obstetric and gynecologic infectious disease. New York: Raven Press, 1994: 693–9.

    Google Scholar 

  10. Abdallah A. Gold v Haringey Health Authority. All England Law Reports 1987; 2: 888–96.

    Google Scholar 

  11. Young R, Platt L, Ledger W. Prophylactic cefoxitin in cesarean section. Lancet 1983; 28: 269–89.

    Google Scholar 

  12. Kreutner K, Del Bene VE, Delamar D, et al. Perioperative cephalosporin prophylaxis in cesarean section: effects on endometritis in the high-risk patient. Am J Obstet Gynecol 1979; 134: 925–35.

    PubMed  CAS  Google Scholar 

  13. De Palma RT, Leveno KJ, Cunningham FG, et al. Identification and management of women at high risk for pelvic infection following cesarean section. Obstet Gynecol 1980; 55 Suppl.: 185–91S.

    Article  Google Scholar 

  14. Davey PG, Parker SE, Crombie IK, et al. The cost effectiveness of amoxicillin/clavulanic acid as antibacterial prophylaxis in abdominal and gynaecological surgery. PharmacoEconomics 1995; 4: 347–56.

    Article  Google Scholar 

  15. Lynch W, Malek M, Davey PG, et al. Costing wound infection in a Scottish hospital. PharmacoEconomics 1992; 2: 163–70.

    Article  PubMed  CAS  Google Scholar 

  16. Shulkin DJ, Kinosian B, Glick H, et al. The economic impact of infections: an analysis of hospital costs and charges in surgical patients with cancer. Arch Surg 1993; 128: 449–52.

    Article  PubMed  CAS  Google Scholar 

  17. Gorbach SL. A funny thing happened… Infect Dis Clin Pract 1994; 3: 49–51

    Article  Google Scholar 

  18. Daschner F. Unnecessary and ecological cost of hospital infection. J Hosp Infect 1991; 18 Suppl. A: 73–8.

    Article  PubMed  Google Scholar 

  19. Crombie IK, Davies HTO, Abraham SCS, et al. The audit handbook — improving health care through clinical audit. Chichester: John Wiley & Sons, 1993: 1–225

    Google Scholar 

  20. Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure and patient risk index. Am J Med 1991; 91 Suppl. 3B: 152–7S.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davey, P. Antibiotic Policies. Drugs 52 (Suppl 2), 83–87 (1996). https://doi.org/10.2165/00003495-199600522-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199600522-00017

Keywords

Navigation